Skip to content
Open menu Close menu

Professor Alison Blenkinsopp

PositionProfessor of the Practice of Pharmacy
LocationM28 Richmond Building
DepartmentBradford School of Pharmacy

Research Interests (key words only)

Medicines optimisation, safe use of medicines, care transitions, primary care, community pharmacy

Administrative Responsibilities

  • Research Lead for Medicines Optimisation, School of Pharmacy
  • Member, Pharmacy Leadership Board
  • Member, GENOVATE Institutional Board


Alison currently holds research Chair in the Practice of Pharmacy at University of Bradford where she leads the Medicines Optimisation research group and is a member of the School of Pharmacy Leadership Board and MPharm teaching team.

A leading applied health research leader in the field of medicines optimization, her studies develop and test interventions to improve safety and maximize effective use of medicines for patient benefit. She has research leadership roles in University of Bradford’s Dementia Doctoral Training Centre and Yorkshire & Humber AHSN’s Medicines Optimisation Translational Research community.

Her current national medicines and pharmacy policy roles include Vice Chair of the British National Formulary Committee, Chair of national Pharmacy Health & Social Care Network, and member of the CQC Medicines Optimisation Group. She is lead author of best-selling pharmacy textbook 'Symptoms in the Pharmacy' now in its 7th edition and published in five languages.

Study History

  • 1981: BPharm (1st), University of Bradford
  • 1988: DPhil, Aston University
  • 1992: Cert. Managing Health Services, Open University

Professional History

  • 1981: MRPharmS
  • 1982-1988: Lecturer in Pharmacy Practice / Part-time PhD studies Aston University
  • 1988-present: Self employed consultant in pharmacy and health care
  • 1988-1991: Lecturer in Pharmacy Practice, University of Bradford
  • 1991-1995: Director, NHS Centre for Pharmacy Postgraduate Education (England), North West Regional Health Authority/University of Manchester
  • 1995-1999: Senior Lecturer in Health Services Research, Keele University Department of Medicines Management (0.6WTE)
  • 1999-2011: Professor of the Practice of Pharmacy, Department of Medicines Management, Keele University School of Pharmacy (0.6WTE)
  • 2001: Charter Gold Medal of the Royal Pharmaceutical Society of Great Britain
  • 2002: Fellowship of the Royal Pharmaceutical Society of Great Britain
  • 2009: OBE (Services to Healthcare)
  • 2015: Faculty Fellowship, Royal Pharmaceutical Society

Professional Activities


  • Deputy Chair, National Joint Formulary Committee (BNF). The British National Formulary is
  • CQC Medicines Optimisation Group
  • Deputy Editor, International Journal of Pharmacy Practice
  • Chair, national pharmacy Health & Social Care Network


  • Expert Advisory Group to the Royal Pharmaceutical Society Commission on future models of care through pharmacy 2013
  • Member, MHRA Committee on Safety of Medicines 1999-2005
  • Council of the Royal Pharmaceutical Society of Great Britain 1988-2006

Research Areas

The University of Bradford’s Medicines Optimisation research group’s strategic themes are in safe use of medicines for older people at transitions (across care settings and of life/disease stage). Dementia and cardiology are the group’s clinical research focus in the context of the multiple morbidities inevitably associated with older age. Using health services research methods, studies establish how current health systems and patient pathways can be enhanced to improve safety and quality of care for patients. By studying the experiences of patients and healthcare staff interventions are co-produced. The research is characterized by strong and effective academic collaborations together with close working with patients and other stakeholders in NHS and social care. Recently-awarded research funding is almost £3 million from sources including NIHR (5 year Programme Grant for Applied Research, PGfAR), Alzheimer’s Society, and partnerships with NHS Trusts in the region.

Alison is currently:

  1. Joint Chief Investigator (with Professor Gerry Armitage, UoB) of the ISCOMAT (Improving Safety and Continuity of Medicines management At Transitions of care) research programme. A 5-year programme developing and testing a complex intervention across the patient journey after a hospital admission for heart failure
  2. Workstream lead/co-app in a NIHR Programme: Improving the Management of Pain in Advanced Cancer in the CommuniTy (IMPACCT) led by CI Professor Mike Bennett at University of Leeds. The medicines management/pharmacy workstream encompasses a pharmacoepidemiology study of prescribing patterns of analgesics in the last year of life and investigation of interventions to improve pain management including non-medical prescribing and community pharmacy medicines reviews
  3. Medicines optimisation theme lead in UoB’s Dementia Doctoral Traning Centre which focuses on transitions in care setting and disease/life stages and lead supervisor for two of its seven Doctoral fellowships
  4. Academic lead for the General Pharmaceutical Council’s (GPhC) suite of national surveys of pharmacist pre-registration trainees, pre-registration tutors and pharmacy technician pre-registration trainees. The surveys form part of the GPhC’s programme of work on quality of education and training for pharmacy professionals

Current Projects

  • Improving the Safety and Continuity Of Medicines management Across Transitions of care (ISCOMAT). NIHR Programme Grant for Applied Research
  • Improving the management of cancer pain in the community (IMPACCT) (NIHR Programme Grant). Workstream lead - Medicines Management. NIHR Programme Grant for Applied Research


Research Collaborations

  • Universities of Leeds & York (Improving the management of cancer pain in the community, IMPACCT)
  • National Institute for Cardiovascular Outcomes Research (NICOR)
  • Community Pharmacy West Yorkshire


  • 2008-present: Chair, National Pharmacy Health & Social Care Network
  • 1996-present: Educational Adviser, Communications International Group


  • Community pharmacists' experience and perceptions of the New Medicines Service (NMS).  Lucas B, Blenkinsopp A. Int J Pharm Pract. 2015 Dec; 23(6):399-406. doi: 10.1111/ijpp.12180. Epub 2015 Feb 25
  • Ziegler L, Bennett M, Blenkinsopp A, Coppock S. Non-medical prescribing in palliative care: a regional survey. Palliat Med. 2015 Feb; 29(2):177-81. doi: 10.1177/0269216314557346. Epub 2014 Dec 12. PMID: 25501312
  • Gerard K, Tinelli M, Latter S, Smith A, Blenkinsopp A. Patients' valuation of the prescribing nurse in primary care: a discrete choice experiment. Health Expect. 2015 Dec;18(6):2223-35. doi: 10.1111/hex.12193. Epub 2014 Apr 11
  • Smith A, Latter S, Blenkinsopp A. Safety and quality of nurse independent prescribing: a national study of experiences of education, continuing professional development clinical governance. J Adv Nurs. 2014 Nov;70(11):2506-17. doi: 10.1111/jan.12392. Epub 2014 Apr 4
  • Urban R, Armitage G, Morgan J, Marshall K, Blenkinsopp A & Scally A. Custom and practice: A multi-center study of medicines reconciliation following admission in four acute hospitals in the UK. Res Social Adm Pharm. 2014 Mar-Apr;10(2):355-68. doi: 10.1016/j.sapharm.2013.06.009. Epub 2014 Feb 14
  • Ngwerume K, Watson M, Bond C, Blenkinsopp A. An evaluation of an intervention designed to improve the evidence-based supply of non-prescription medicines from community pharmacies. Int J Pharm Pract. 2015 Apr;23(2):102-10. doi: 10.1111/ijpp.12118. Epub 2014 May 20
  • Tinelli M, Blenkinsopp A, Latter S, Smith A, Chapman SR. Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care. Health Expect. 2015 Oct;18(5):1241-55. doi: 10.1111/hex.12099. Epub 2013 Jun 24
  • Alam MF, Blenkinsopp A, Cohen D, Davies P, Hodson K, Hughes L, James D, Longley M, O’Brien C, Smith M, Turnbull L. Evaluation of the Discharge Medicines Review Service: Final Report (2014) Universities of South Wales, Cardiff & Bradford
  • Savage I, Blenkinsopp A, Bennett M. ”Like doing a jigsaw with half the pieces missing”: community pharmacists and the management of cancer pain in the community. Int J Pharm Pract 2013; 21(3):151-60
  • McLean SL, Blenkinsopp A, Bennett MI. Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts. J Pain Palliat Care Pharmacother. 2013 Jun;27(2):132-5. doi: 10.3109/15360288.2013.782937. Epub 2013 Apr 29
  • Mills E, Blenkinsopp A, Black P. Quality management in pharmacy pre-registration training: Current practice. Pharm Educ 2013 (13) July 7
  • Mills E, Blenkinsopp A, Black P. Quality management in Medical Foundation training: Lessons for pharmacy. Pharm Educ 2013 (13) July 7
  • Mills E, Blenkinsopp A, Black P. Quality management in pharmacy pre-registration training: Recommendations for the future. Pharm Educ 2013 (13) July 7
  • Blenkinsopp A, Horgan J, McManus R, Little R, George E, Silcock J, Beach J, Smith S. (2013) Evaluation of costs and benefits of a community pharmacy cardiovascular risk assessment service
  • Blenkinsopp A, Bond C, Raynor DK. Medication Reviews. Br J Clinical Pharmacol 2012, 74(4):573-80
  • Bond C, Raynor DK, Blenkinsopp A. Prescribing Partnerships. Br J Clinical Pharmacol 2012, 74(4):581-8
  • De Simoni A, Mullis R, Clyne W, Blenkinsopp A. Medicines optimisation in primary care: can community pharmacies deliver? Editorial. Brit J Gen Pract 2012, 62: 398-9
  • Gerard K, Tinelli M, Latter S, Blenkinsopp A, Smith A, Chapman S. Valuing the extended role of prescribing pharmacist in general practice: Results from a discrete choice experiment. Value in Health 2012, 15(5):699-707
  • Latter S, Smith A, Blenkinsopp A, Nicholls P, Little P, Chapman S. Are nurse and pharmacist independent prescribers making clinically appropriate prescribing decisions? An analysis of consultations using the Medication Appropriateness Index. J Hth Serv Res Policy 2012, 17(3):149-56
  • Latter S, Blenkinsopp A. Non-medical prescribing: current and future contribution of pharmacists and nurses. Int J Pharm Pract. 2011 Dec;19(6):381-2
  • Latter S, Blenkinsopp A, Smith A, Chapman S, Tinelli M et al. Evaluation of nurse and pharmacist independent prescribing. Final Report (2011). Department of Health Policy Research Programme. University of Southampton / Keele University
  • Bennett MI, Bagnall AM, Raine G, Closs SJ, Blenkinsopp A, Dickman A, Ellershaw J. Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis. Clin J Pain 2011; 27(7):623-30
  • Tinelli M, Blenkinsopp A, Bond CM. Development and validation of a patient satisfaction score for a community pharmacy medicines management service Int J Pharm Pract 2011; 19(3):144-55
  • Tann J, Blenkinsopp A, Grime J, Evans A. The Great Boundary Crossing: Perceptions on training pharmacists as prescribers in the UK. Health Ed J 2010; 69: 183-191
  • Horgan JMP, Blenkinsopp A, McManus RJ. Evaluation of a cardiovascular disease opportunistic risk assessment pilot (‘Heart MOT’ service) in community pharmacies. J Pub Hlth 2010; 32:110 – 116
  • Watson MC, Blenkinsopp A. The feasibility of providing community pharmacy based services for alcohol misuse: a systematic review. Int J Pharm Pract 2009; 17(4): 199-205
  • Blenkinsopp A, Holmes J, Mitra G, Pringle M. Joining up self care: evaluation of a Primary Care Trust-wide programme of support for self care. Primary Care Research and Development 2009; 10: 83-89
  • Bond CM, Blenkinsopp A, Inch J, Celino G, Gray N. The effect of the new community pharmacy contract on the community pharmacy workforce (Research Monograph). Pharmacy Practice Research Trust, London 2008
  • Phelan P, Blenkinsopp A, Foster ME, Thomas E, Hay EM. Pharmacist-led medication review for knee pain in older adults: content, process and outcomes. Int J Pharm Pract 2008; 16: 347-55
  • Blenkinsopp A, Celino G, Bond C, Inch J, Gray N. Medicines use review: adoption and spread of a new service innovation. International Journal of Pharmacy Practice 2008; 16(4): 271-276
  • Tann J, Blenkinsopp A, Evans A, Grime J. Beating the Bounds? General medical practitioner (GP) and pharmacist perspectives on the innovation of pharmacist prescribing in the UK National Health Service. Prometheus 2008; 26: 125-139
  • Bissell P, Blenkinsopp A, Short D, Mason L. Patients’ views and experiences of a medicines management service. Health and Social Care in the Community 2008; 16(4): 363-369
  • Blenkinsopp A, Tann J, Evans A, Grime JC. Opportunity or threat? GP perceptions of pharmacist prescribing. International Journal of Pharmacy Practice
  • Blenkinsopp A, Bond C. The potential and pitfalls of medicines management: what have we learned so far? Disease Management and Health Outcomes 2008; 16(2):79-86
  • Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P. Patients’ experiences with a community pharmacy medications management service: focus on attitudes, expectations and satisfaction. Ann Pharmacother 2007; 41: 1962-70
  • Raynor DK, Blenkinsopp A, Knapp P Knapp P, Nicolson DJ, Grime J, Pollock K , Dorer G, Gilbody S, Dickinson D, Maule AJ, Spoor P. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007 (5):iii, 1-160. Review
  • Grime J, Blenkinsopp A, Raynor DK, Pollock K, Knapp P. The role and value of written information for patients about individual medicines: a systematic review Health Expectations 2007; 10: 286-298
  • Blenkinsopp A, Hassey A, Dorer G. Medicines in primary care: towards a patient-centred approach to quality. Qual Prim Care 2007; 15: 213-9
  • Blenkinsopp A, Celino G, Bond CM, Inch J. Medicines Use Review: The first year of a new community pharmacy service. PharmJ 2007; 278: 218-223
  • The community pharmacy medicines management evaluation project team. The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease. Family Practice 2007 24(2): 189-200
  • Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007; 63(2):148-56


  • Blenkinsopp A, Paxton P, Blenkinsopp J. Symptoms in the Pharmacy (7th ed). Oxford: Wiley: 2013
  • Chambers R, Wakley G, Blenkinsopp A. Promoting patients’ self care in primary care. Oxford: Radcliffe Press 2006
  • Blenkinsopp A, Panton RS, Anderson A. Health promotion for community pharmacists (2nd ed). Oxford University Press 2000

Book Chapters

  • Blenkinsopp A, Anderson A, Panton R. (2015) Promoting Health. In Taylor P, Harding G, eds. Pharmacy Practice. Oxford University Press. 2015
  • Blenkinsopp A, Kinnear M. (2011) Research and Development. In: Hospital Pharmacy (ed. Stephens M). Pharmaceutical Press.
  • Anderson C, Blenkinsopp A. (2010) Health Education opportunities. In: Pharmaceutical Public Health (ed Krska J). Pharmaceutical Press, London
  • Blenkinsopp A, Dorer G, Duerden M, Jester R. (2009) Interface of care and communication. In: Medication Safety. Cambridge University Press
  • Blenkinsopp A, Gray N. (2008) Online information and supply systems for patients, the public and professionals. In Bond, ed. Harnessing Health Information: Using medicines information. Radcliffe Medical Press, Oxford
  • Armstrong M, Anderson C, Blenkinsopp A, Lewis R. (2005) Promoting health through community pharmacies. In Scriven, ed. Health Promoting Practice. Palgrave Macmillan
  • Blenkinsopp A. (2004) Ongoing support - the postprescription phase. In Bond C, ed. Concordance. London : Pharmaceutical Press
  • Blenkinsopp A, Bond C. (2004) Self-care and medication. In Jones et al, ed. Textbook of Primary Medical Care. Oxford: University Press
  • Blenkinsopp A, Bond C. (2004) The future healthcare workforce in pharmacy. In Celia Davies, ed. The future health workforce. Hampshire: Palgrave Macmillan
  • Anderson C, Blenkinsopp A. (2001) Health, disease and health education. In Harman R, ed. Handbook of Pharmacy Health Education. Cambridge: Cambridge University Press


Alison’s portfolio of work includes several large scale studies to evaluate effects of major medicines policy initiatives and which have influenced national and local health services. These include the NHS evaluation of the quality and safety of nurse and pharmacist independent prescribing in order to inform planning for current and future prescribers, and research to evaluate the impact of changes to the national community pharmacy NHS contractual framework on patients, practitioners and care delivery. These studies were characterised by the active involvement of stakeholders at all stages including working with change agents at all system levels after study completion to implement findings.

The first systematic review of evidence of the contribution of community pharmacy to improving the public’s health was co-led by Alison with Professor Claire Anderson. This work was instrumental in informing a Department of Health White Paper and the subsequent development of the Healthy Living Pharmacy model in England.

Public/Academic/Stakeholder Engagement

Alison works and collaborates with an extensive network of stakeholders at individuals and organisational levels that includes policy makers, regulators, clinicians, patients, professional bodies and academics.


Share this